Aligos Therapeutics Inc (ALGS) — Financial Flexibility Index
Aligos Therapeutics Inc (ALGS) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-23.06 Million (operating CF $-23.13 Million minus capex $69.00K) represents -1% of total liabilities ($32.77 Million). Check Aligos Therapeutics Inc (ALGS) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aligos Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Aligos Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see Aligos Therapeutics Inc (ALGS) cash conversion ratio.
Annual Financial Flexibility Index for Aligos Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Aligos Therapeutics Inc. Explore debt repayment capacity of Aligos Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.35x | $-82.07 Million | $-82.50 Million | $34.99 Million | ▼ -188.2% |
| 2024 | -0.81x | $-80.61 Million | $-80.74 Million | $99.07 Million | ▲ +38.8% |
| 2023 | -1.33x | $-78.98 Million | $-79.00 Million | $59.45 Million | ▲ +27.5% |
| 2022 | -1.83x | $-78.45 Million | $-79.39 Million | $42.79 Million | ▲ +19.1% |
| 2021 | -2.27x | $-114.77 Million | $-115.66 Million | $50.64 Million | ▼ -42.1% |
| 2020 | -1.60x | $-72.20 Million | $-74.26 Million | $45.26 Million | ▼ -666.7% |
| 2019 | -0.21x | $-43.98 Million | $-46.77 Million | $211.41 Million | ▼ -615.3% |
| 2018 | -0.03x | $-3.53 Million | $-6.05 Million | $121.48 Million | — |